Your browser doesn't support javascript.
loading
The Incidence and Health Care Resource Burden of the Myelodysplastic Syndromes in Patients in Whom First-Line Hypomethylating Agents Fail.
Cogle, Christopher R; Kurtin, Sandra E; Bentley, Tanya G K; Broder, Michael S; Chang, Eunice; Megaffin, Scott; Fruchtman, Steven; Petrone, Michael E; Mukherjee, Sudipto.
Afiliação
  • Cogle CR; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA christopher.cogle@medicine.ufl.edu.
  • Kurtin SE; University of Arizona, Tucson, Arizona, USA.
  • Bentley TG; Partnership for Health Analytic Research, LLC, Beverly Hills, California, USA.
  • Broder MS; Partnership for Health Analytic Research, LLC, Beverly Hills, California, USA.
  • Chang E; Partnership for Health Analytic Research, LLC, Beverly Hills, California, USA.
  • Megaffin S; Churchill Pharmaceuticals, LLC, King of Prussia, Pennsylvania, USA.
  • Fruchtman S; Onconova Therapeutics, Inc., Newtown, Pennsylvania, USA.
  • Petrone ME; Onconova Therapeutics, Inc., Newtown, Pennsylvania, USA.
  • Mukherjee S; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, Ohio, USA.
Oncologist ; 22(4): 379-385, 2017 04.
Article em En | MEDLINE | ID: mdl-28283585

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Incidence_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Incidence_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article